While companies developing solutions that address the current pandemic may be receiving an influx of financial support, recovery for companies in other segments of the industry is slow.
The immense challenges posed by the coronavirus pandemic are fueling interest in cloud computing among vaccine researchers, clinicians, healthcare companies and patients across Asia.
The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
Peter Micca of Deloitte discusses the changes that are happening within the healthcare ecosystem as a whole.
AdvaMed states that the huge tax increase will have a significant impact on employment and investment.
Across the continent, governments and hospitals are purchasing robotics systems from abroad as well as developing the technologies themselves.
The company is dedicating more funds to research, development and innovative projects.
Before accepting money, the following is a guide to your due diligence process.
China’s medtech influence is beginning to threaten the West’s dominance.
As competition for market share and investors tightens, well-designed market research can significantly enhance a medtech company’s strategy.